Billionaire Mason Hawkins’ 5 Stock Picks with Huge Upside Potential

3. Bio-Rad Laboratories Inc. (NYSE:BIO)

Number of Hedge Fund Investors: 44

Average Analyst Price Estimate: $413

Upside Potential: 30.69%

Life sciences research and clinical diagnostics products company Bio-Rad Laboratories Inc. (NYSE:BIO) ranks third in our list of the stocks in Mason Hawkins’ portfolio with upside potential.

As of the end of the third quarter of 2023, 44 hedge funds out of the 910 funds tracked by Insider Monkey had stakes in Bio-Rad Laboratories Inc. (NYSE:BIO). The biggest hedge fund stakeholder of Bio-Rad Laboratories Inc. (NYSE:BIO) during this period is Israel Englander’s Millennium Management which owns a $135 million stake in Bio-Rad Laboratories Inc. (NYSE:BIO).